Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population

  

LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer

Alvydas Vezelis, Julija Simiene, Daiva Dabkeviciene, Marius Kincius, Albertas Ulys, Kestutis Suziedelis, Sonata Jarmalaite, Feliksas Jankevicius, Nihal Ahmad

Journal of Oncology.2021; 2021: 1.     CrossRef

Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network

Jacklyn N. Hellwege, Sarah Stallings, Eric S. Torstenson, Robert Carroll, Kenneth M. Borthwick, Murray H. Brilliant, David Crosslin, Adam Gordon, George Hripcsak, Gail P. Jarvik, James G. Linneman, Parimala Devi, Peggy L. Peissig, Patrick A. M. Sleiman, H

Scientific Reports.2019;[Epub]     CrossRef

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China

Yanhua Li, Jiuping Wang, Juan Wang, Yunfeng Xiao, Bin Xu, Hongwei Li, Liu Yang, Xiaoke Hao, Yueyun Ma

Virology Journal.2017;[Epub]     CrossRef

The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects

Deepa R Mhatre, Smita D Mahale, Mohammed I Khatkhatay, Swati K Achrekar, Swapna S Desai, Dhanashree D Jagtap, Jayesh V Dhabalia, Hemant B Tongaonkar, Sucheta P Dandekar, Anand M Varadkar

SpringerPlus.2015;[Epub]     CrossRef

Promoter polymorphisms of NDUFA4 gene were associated with prostate enlargement of benign prostatic hyperplasia

Hyun Kyung Park, Su Kang Kim

Molecular & Cellular Toxicology.2015; 11(4): 401.     CrossRef

Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia

SU KANG KIM, JOO-HO CHUNG, HYUN CHUL PARK, JUN HO KIM, JAE HONG ANN, HUN KUK PARK, SANG HYUP LEE, KOO HAN YOO, BYUNG-CHEOL LEE, YOUNG OCK KIM

Experimental and Therapeutic Medicine.2015; 10(5): 1990.     CrossRef